Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Crossbeta Biosciences B.V. logo — company profile

Crossbeta Biosciences B.V.

Founded 2005 The Netherlands The Netherlands 3 employees Biotechnology

General Information

Company Name Crossbeta Biosciences B.V.
Founded Year 2005
Location The Netherlands The Netherlands +1
Employees 3
Industries Biotechnology
Social

Get notified when Crossbeta Biosciences B.V. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Crossbeta Biosciences B.V.

Crossbeta Biosciences B.V. is a biotechnology company founded in 2005 with a focus on developing drugs for unmet needs related to misfolded protein diseases. The company's goal is to transform hope into quality of life by targeting these diseases. It has developed an innovative oligomer stabilization technology that allows for the development of drugs to selectively target and prevent misfolded protein oligomers from exerting harmful effects. The company's research and drug discovery programs specifically target misfolded proteins, which have been linked to diseases such as Alzheimer’s and Parkinson’s disease, as well as type 2 diabetes. Crossbeta Biosciences has completed a high throughput screening campaign with 100,000 compounds, resulting in the selection of 5 hit classes with more than 50% neutralizing effect on oligomer-induced neurotoxicity for its Alzheimer program. Overall, Crossbeta Biosciences is positioned as a promising player in the biotechnology industry with its innovative approach to addressing unmet medical needs associated with misfolded protein diseases.

No funding data available for Crossbeta Biosciences B.V. yet.

Get notified when Crossbeta Biosciences B.V. raises funding

Crossbeta Biosciences B.V. Alternatives & Competitors

Crossbeta Biosciences B.V. vs
ProMIS™ Neurosciences, Inc.
ProMIS™ Neurosciences, Inc. United States

Precision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Parkinson’s...

Unknown
22 employees
Biotechnology, Health Care
Crossbeta Biosciences B.V. vs
Acelot
Acelot United States

A new paradigm for neurodegeneration.

Grant
17 employees
Biotechnology, Health Care
Crossbeta Biosciences B.V. vs
Allinky Biopharma
Allinky Biopharma

Among the therapeutic areas of partnering interest, for the top pharmaceutical companies, oncology,...

3 employees
Biotechnology, Health Care

FAQ About Crossbeta Biosciences B.V.

"We aim to develop drugs for unmet needs, which transform hope into quality of life." Crossbeta Biosciences is a biotechnology company developing and executing drug discovery programs in the area of misfolded protein diseases. All misfolded proteins in our body contain a crossbeta structure, whic...
Crossbeta Biosciences B.V. was founded in 2005.
Crossbeta Biosciences B.V. is headquartered in The Netherlands.
Crossbeta Biosciences B.V. operates in the following industries: Biotechnology.
Crossbeta Biosciences B.V. has approximately 3 employees.
Top alternatives and competitors to Crossbeta Biosciences B.V. include ProMIS™ Neurosciences, Inc., Acelot, Allinky Biopharma, Wren Therapeutics, Primary Peptides . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Crossbeta Biosciences B.V. and ProMIS™ Neurosciences, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Crossbeta Biosciences B.V. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy